PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...
5 天
Zacks.com on MSNPTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest ...
Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...
NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...
Neurons that secrete the neuropeptide orexin help mice decide between exercise and snacking.
PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果